Incidence of submicroscopic deletions vary according to disease entities and chromosomal translocations in hematologic malignancies: investigation by fluorescence in situ hybridization

Cancer Genetics and Cytogenetics

Volumn 175, Issue 2, 2007, Pages 166-168

  Moon, Hee Won ^a   Chang, Yoon Hwan ^b   Kim, Tae Young ^c   Oh, Bo Ra ^c   Min, Hyun Chung ^c   Kim, Byoung Kook ^c   Ahn, Hyo Seop ^c   Cho, Han Ik ^c   Lee, Dong Soon ^c  

^a Ewha Womans University School of Medicine   (South Korea)

^b Korea Cancer Center Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; TRANSCRIPTION FACTOR RUNX1;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE REARRANGEMENT; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS;

CHROMOSOME DELETION; CORE BINDING FACTOR ALPHA 2 SUBUNIT; HEMATOLOGIC NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; ONCOGENE PROTEINS, FUSION; TRANSLOCATION, GENETIC;

EID: 34249810636     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.01.012     Document Type: Article

References (8)

1. Attarbaschi A., Mann G., Konig M., Dworzak M.N., Trebo M.M., Muhlegger N., Gadner H., and Haas O.A. Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1+ acute lymphoblastic leukemia: an interphase FISH analysis. Leukemia 18 (2004) 1611-1616
2. Huntly B.J., Reid A.G., Bench A.J., Campbell L.J., Telford N., Shepherd P., Szer J., Prince H.M., Turner P., Grace C., Nacheva E.P., and Green A.R. Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia. Blood 98 (2001) 1732-1738
3. Kolomietz E., Al-Maghrabi J., Brennan S., Karaskova J., Minkin S., Lipton J., and Squire J.A. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood 97 (2001) 3581-3588
4. Lee D.S., Lee Y.S., Yun Y.S., Kim Y.R., Jeong S.S., Lee Y.K., She C.J., Yoon S.S., Shin H.R., Kim Y., and Cho H.I. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression. Genes Chromosomes Cancer 37 (2003) 291-299
5. Yunis J.J. Comparative analysis of high-resolution chromosome techniques for leukemic bone marrows. Cancer Genet Cytogenet 7 (1982) 43-50
6. Sinclair P.B., Nacheva E.P., Leversha M., Telford N., Chang J., Reid A., Bench A., Champion K., Huntly B., and Green A.R. Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood 95 (2000) 738-743
7. Yoong Y., VanDeWalker T.J., Carlson R.O., Dewald G.W., and Tefferi A. Clinical correlates of submicroscopic deletions involving the ABL-BCR translocation region in chronic myeloid leukemia. Eur J Haematol 74 (2005) 124-127
8. Reid A.G., Huntly B.J., Hennig E., Niederwieser D., Campbell L.J., Bown N., Telford N., Walker H., Grace C.D., Deininger M.W., Green A.R., and Nacheva E.P. Deletions of the derivative chromosome 9 do not account for the poor prognosis associated with Philadelphia-positive acute lymphoblastic leukemia. Blood 99 (2002) 2274-2275